120 related articles for article (PubMed ID: 1519525)
1. Effect of high-current stimulation in patients with sustained ventricular tachycardia rendered noninducible by antiarrhythmic drugs.
Hook BG; Marchlinski FE; Josephson ME; Buxton AE
Am J Cardiol; 1992 Sep; 70(7):752-7. PubMed ID: 1519525
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
Volgman AS; Zheutlin TA; Mattioni TA; Parker MA; Kehoe RF
Am J Cardiol; 1992 Sep; 70(7):758-63. PubMed ID: 1519526
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease.
Friehling TD; Lipshutz H; Marinchak RA; Stohler JL; Kowey PR
Am J Cardiol; 1990 Jun; 65(20):1328-33. PubMed ID: 2343820
[TBL] [Abstract][Full Text] [Related]
4. [Comparative effects of anti-arrhythmia agents on ventricular refractory period and prevention of ventricular tachycardia induced by stimulation].
Bru P; Collet F; Metge M; Cointe R; Gérard R; Lévy S
Arch Mal Coeur Vaiss; 1992 Sep; 85(9):1311-6. PubMed ID: 1290392
[TBL] [Abstract][Full Text] [Related]
5. Utility of the signal-averaged electrocardiogram in patients presenting with sustained ventricular tachycardia or fibrillation while on an antiarrhythmic drug.
Nalos PC; Gang ES; Mandel WJ; Myers MR; Oseran DS; Lass Y; Peter T
Am Heart J; 1988 Jan; 115(1 Pt 1):108-14. PubMed ID: 3336965
[TBL] [Abstract][Full Text] [Related]
6. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome.
Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH
Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601
[TBL] [Abstract][Full Text] [Related]
7. Discordant results of programmed ventricular stimulation at different right ventricular sites in patients with and without spontaneous sustained ventricular tachycardia: a prospective study of 56 patients.
Doherty JU; Kienzle MG; Buxton AE; Marchlinski FE; Waxman HL; Josephson ME
Am J Cardiol; 1984 Aug; 54(3):336-42. PubMed ID: 6465014
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the need to modify antiarrhythmic therapy because of drug intolerance or inefficacy in patients evaluated by electrophysiology study.
Ujhelyi MR; Fisher JR; Chow MS; Kluger J
Am Heart J; 1993 Aug; 126(2):352-9. PubMed ID: 8338006
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
10. Electrocardiographic correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease.
Duff HJ; Mitchell LB; Gillis AM; Sheldon RS; Chudleigh L; Cassidy P; Chiamvimonvat N; Wyse DG
Circulation; 1993 Sep; 88(3):1054-62. PubMed ID: 8353867
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR
Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337
[TBL] [Abstract][Full Text] [Related]
12. Discrepant effects of mexiletine on cycle length of ventricular tachycardia and on the effective refractory period in the area of slow conduction.
Aizawa Y; Chinushi M; Kitazawa H; Washizuka T; Abe A; Shibata A; Kodama I
Heart; 1996 Mar; 75(3):281-6. PubMed ID: 8800993
[TBL] [Abstract][Full Text] [Related]
13. Induced sustained ventricular tachycardia in nonischemic dilated cardiomyopathy: dependence on clinical presentation and response to antiarrhythmic agents.
Constantin L; Martins JB; Kienzle MG; Brownstein SL; McCue ML; Hopson RC
Pacing Clin Electrophysiol; 1989 May; 12(5):776-83. PubMed ID: 2471163
[TBL] [Abstract][Full Text] [Related]
14. Amiloride. Antiarrhythmic and electrophysiologic actions in patients with inducible sustained ventricular tachycardia.
Duff HJ; Mitchell LB; Kavanagh KM; Manyari DE; Gillis AM; Wyse DG
Circulation; 1989 Jun; 79(6):1257-63. PubMed ID: 2720927
[TBL] [Abstract][Full Text] [Related]
15. Immediate reproducibility of electrically induced sustained monomorphic ventricular tachycardia before and during antiarrhythmic therapy.
Rosenbaum MS; Wilber DJ; Finkelstein D; Ruskin JN; Garan H
J Am Coll Cardiol; 1991 Jan; 17(1):133-8. PubMed ID: 1987216
[TBL] [Abstract][Full Text] [Related]
16. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.
Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME
J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479
[TBL] [Abstract][Full Text] [Related]
17. Programmed ventricular stimulation using up to two extrastimuli and repetition of double extrastimulation for induction of ventricular tachycardia: a new highly sensitive and specific protocol.
Belhassen B; Shapira I; Sheps D; Laniado S
Am J Cardiol; 1990 Mar; 65(9):615-22. PubMed ID: 2309631
[TBL] [Abstract][Full Text] [Related]
18. Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms.
Rinkenberger RL; Prystowsky EN; Jackman WM; Naccarelli GV; Heger JJ; Zipes DP
Am Heart J; 1982 Feb; 103(2):177-84. PubMed ID: 6798855
[TBL] [Abstract][Full Text] [Related]
19. Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Philadelphia Arrhythmia Group.
Kowey PR; Waxman HL; Greenspon A; Greenberg R; Poll D; Kutalek S; Gessman L; Muenz L
Am J Cardiol; 1990 Mar; 65(9):594-8. PubMed ID: 2309629
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME
Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
